Abstract
Background
It has recently been found that 5-lipoxygenase (5-LO) and cytochrome P450-2J2 (CYP2J2), molecules capable of arachidonic acid (AA) metabolism, might promote cancer cell viability through several mechanisms similar to those of cyclooxygenase-2 (COX-2). We found that not only COX-2 expression, but also the expression of 5-LO and CYP2J2 is up-regulated in head and neck squamous cell carcinoma (HNSCC) cell lines. From these observations, we hypothesized that AA metabolism by 5-LO and/or CYP2J2 may lower the efficacy of anti-cancer effect by COX-2 inhibition.
Methods and Results
Although COX-2 was highly expressed in all cell lines tested, COX-2-specific inhibition showed little growth-inhibitory effect in some cell lines. Inhibition of COX-2 resulted in increased production of LTB4 and 14-15-DHET/EET, metabolites of 5-LO and CYP2J2, respectively. Combined knock-down of COX-2 and 5-LO or CYP2J2 by siRNA results in a decrease in cell proliferation and VEGF production. Furthermore, these results are dependent on 5-LO and CYP2J2 expression in cells.
Conclusion
Therefore, combined inhibition of COX-2 and 5-LO or CYP2J2 may be one way to overcome low efficacy of single inhibition of COX-2 in cancer cells. In addition, combined therapies should be chosen based on the expression of members of other AA metabolism pathways.
Similar content being viewed by others
Abbreviations
- siRNA:
-
small interfering RNA
- CYP2J2:
-
cytochrome P450 family 2-subfamily J-polypeptide 2
- PGE2 :
-
prostaglandin E2
- LTB4 :
-
Leukotriene B4
- DHET:
-
dihydroxyeicosatrienoic acid
- EET:
-
epoxyeicosatrienoic acid
- VEGF:
-
vascular endothelial growth factor
- 5-HETE:
-
5-Hydroxyeicosatetraenoic acid
- cytLTs:
-
cysteinyl-leukotrienes
References
H. Harizi, J.B. Corcuff, N. Gualde, Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends Mol. Med. 14, 461–469 (2008)
S.P. Levick, D.C. Loch, S.M. Taylor, J.S. Janicki, Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation. J. Immunol. 178, 641–646 (2007)
Y. Zheng, J.D. Ritzenthaler, X. Sun, J. Roman, S. Han, Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1. Cancer Res. 69, 896–904 (2009)
N. Arber, Cyclooxygenase-2 inhibitors in colorectal cancer prevention: point. Cancer Epidemiol. Biomarkers Prev. 17, 1852–1857 (2008)
W.G. Tong, X.Z. Ding, M.S. Talamonti, R.H. Bell, T.E. Adrian, LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways. Biochem. Biophys. Res. Commun. 335, 949–956 (2005)
J.G. Jiang, Y.G. Ning, C. Chen, D. Ma, Z.J. Liu, S. Yang, J. Zhou, X. Xiao, X.A. Zhang, M.L. Edin, J.W. Card, J. Wang, D.C. Zeldin, D.W. Wang, Cytochrome p450 epoxygenase promotes human cancer metastasis. Cancer Res. 67, 6665–6674 (2007)
Y.N. Ye, W.K. Wu, V.Y. Shin, I.C. Bruce, B.C. Wong, C.H. Cho, Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke. Carcinogenesis 26, 827–834 (2005)
F. Cianchi, C. Cortesini, L. Magnelli, E. Fanti, L. Papucci, N. Schiavone, L. Messerini, A. Vannacci, S. Capaccioli, F. Perna, M. Luli, V. Fabbroni, G. Perigli, P. Bechi, E. Masini, Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells. Mol. Cancer Ther. 5, 2716–2726 (2006)
M. Barry, R.A. Cahill, G. Roche-Nagle, T.G. Neilan, A. Treumann, J.H. Harmey, D.J. Bouchier-Hayes, Neoplasms escape selective COX-2 inhibition in an animal model of breast cancer. Ir. J. Med. Sci. 178, 201–208 (2009)
S.W. Park, S.G. Lee, S.H. Song, D.S. Heo, B.J. Park, D.W. Lee, K.H. Kim, M.W. Sung, The effect of nitric oxide on cyclooxygenase-2 (COX-2) overexpression in head and neck cancer cell lines. Int. J. Cancer 107, 729–738 (2003)
C. Vincent, R. Fiancette, M. Donnard, D. Bordessoule, P. Turlure, F. Trimoreau, Y. Denizot, 5-LOX, 12-LOX and 15-LOX in immature forms of human leukemic blasts. Leuk. Res. 32, 1756–1762 (2008)
T.C. Delozier, G.E. Kissling, S.J. Coulter, D. Dai, J.F. Foley, J.A. Bradbury, E. Murphy, C. Steenbergen, D.C. Zeldin, J.A. Goldstein, Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues. Drug Metab. Dispos. 35, 682–688 (2007)
A. Catalano, A. Procopio, New aspects on the role of lipoxygenases in cancer progression. Histol. Histopathol. 20, 969–975 (2005)
V.B. O’Donnell, B. Maskrey, G.W. Taylor, Eicosanoids: generation and detection in mammalian cells. Methods Mol. Biol. 462, 5–23 (2009)
L.G. Melstrom, D.J. Bentrem, M.R. Salabat, T.J. Kennedy, X.Z. Ding, M. Strouch, S.M. Rao, R.C. Witt, C.A. Ternent, M.S. Talamonti, R.H. Bell, T.A. Adrian, Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model. Clin. Cancer Res. 14, 6525–6530 (2008)
H. Zhu, W. Glasgow, M.D. George, K. Chrysovergis, K. Olden, J.D. Roberts, T. Eling, 15-lipoxygenase-1 activates tumor suppressor p53 independent of enzymatic activity. Int. J. Cancer 123, 2741–2749 (2008)
Q. Yang, Y. Feng, C.J. Schultz, X.A. Li, H. Wu, D. Wang, Synergistic effect of 15-lipoxygenase 2 and radiation in killing head-and-neck cancer. Cancer Gene Ther. 15, 323–330 (2008)
J.G. Jiang, X.N. Fu, C.L. Chen, D.W. Wang, Expression of cytochrome P450 arachidonic acid epoxygenase 2J2 in human tumor tissues and cell lines. Chin. J. Cancer 28, 93–96 (2009)
J.G. Jiang, C.L. Chen, J.W. Card, S. Yang, J.X. Chen, X.N. Fu, Y.G. Ning, X. Xiao, D.C. Zeldin, D.W. Wang, Cytochrome P450 2 J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. Cancer Res. 65, 4707–4715 (2005)
J.L. Roh, M.W. Sung, S.W. Park, D.S. Heo, D.W. Lee, K.H. Kim, Celecoxib can prevent tumor growth and distant metastasis in postoperative setting. Cancer Res. 64, 3230–3235 (2004)
M.W. Sung, J.L. Roh, B.J. Park, S.W. Park, T.K. Kwon, S.J. Lee, K.H. Kim, Bile acid induces cyclo-oxygenase-2 expression in cultured human pharyngeal cells: a possible mechanism of carcinogenesis in the upper aerodigestive tract by laryngopharyngeal reflux. Laryngoscope 113, 1059–1063 (2003)
S.W. Park, M.W. Sung, D.S. Heo, H. Inoue, S.H. Shim, K.H. Kim, Nitric oxide upregulates the cyclooxygenase-2 expression through the cAMP-response element in its promoter in several cancer cell lines. Oncogene 24, 6689–6698 (2005)
Acknowledgements
We thank Dr. William L. Smith, Dr. Thomas G. Brock and Darryl C. Zeldin for kindly providing us with the cDNA of COX-2, 5-LO and CYP2J2.
This study was supported by a grant from the national R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [Grants no. 0620250] and BK21 project for Medicine, Dentistry and Pharmacy, Korea.
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Materials
Below is the link to the electronic supplementary material.
Supplementary material 1
(DOC 142 kb)
Supplementary material 2
(DOC 76 kb)
Supplementary material 3
(DOC 108 kb)
Supplementary material 4
(DOC 153 kb)
Supplementary material 5
(DOC 148 kb)
Rights and permissions
About this article
Cite this article
Park, SW., Heo, DS. & Sung, MW. The shunting of arachidonic acid metabolism to 5-lipoxygenase and cytochrome p450 epoxygenase antagonizes the anti-cancer effect of cyclooxygenase-2 inhibition in head and neck cancer cells. Cell Oncol. 35, 1–8 (2012). https://doi.org/10.1007/s13402-011-0051-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13402-011-0051-7